Both in Pharmaceuticals
Xencor vs MBX Biosciences
Over the past year XNCR returned +155.7% and MBX returned +154.5%; their daily moves had a correlation of 0.31.
XNCR +155.7% MBX +154.5%Growth of $1, one year, split-adjusted
| Metric | XNCR | MBX |
|---|---|---|
| Price | $35.03 | $52.48 |
| Market cap | $2.60B | $2.53B |
| Today | +14.33% | −4.58% |
| 1 month | +43.8% | −7.8% |
| 6 months | +169.3% | +63.4% |
| Year to date | +128.8% | +66.4% |
| 1 year | +151.3% | +154.6% |
| Revenue growth (YoY) | +17.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −42.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | — |
| Net cash | $351.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 48.5% |
| Short % of float | 17.0% | 15.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).